Basilea Gets $13M from BARDA for Ceftibuten-Ledaborbactam
28 May 2026 //
GLOBENEWSWIRE
Basilea Secures BARDA Contract For Ceftibuten-Ledaborbactam
25 Sep 2025 //
GLOBENEWSWIRE
Basilea In-Licenses Novel Oral Antibiotic for Clinical Phase 3
14 Aug 2025 //
GLOBENEWSWIRE

Market Place
Sourcing Support